Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024)
With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic dysfunction-associated non-alcoholic fatty liver disease has become the most prevalent chronic liver disease. This condition frequently occurs in Chinese patients with alcoholic liver disease and chronic hepatitis B. To address the impending public health crisis of non-alcoholic fatty liver disease and its underlying metabolic issues, the Chinese Society of Hepatology and the Chinese Medical Association convened a panel of clinical experts to revise and update the "Guideline of prevention and treatment of non-alcoholic fatty liver disease (2018, China)". The new edition, titled "Guideline for the prevention and treatment of metabolic dysfunction-associated fatty liver disease (Version 2024)", offers comprehensive recommendations on key clinical issues, including screening and monitoring, diagnosis and evaluation, treatment, and follow-up for metabolic dysfunction-associated fatty liver disease and metabolic dysfunction-associated steatotic liver disease. Metabolic dysfunction-associated fatty liver disease is now the preferred English term and is used interchangeably with metabolic dysfunction-associated steatotic liver disease. Additionally, the guideline emphasizes the importance of multidisciplinary collaboration among hepatologists and other specialists to manage cardiometabolic disorders and liver disease effectively.
Authors
- Jidong Jia (ORCID: https://orcid.org/0000-0002-4673-8890)
- Lai Wei (ORCID: https://orcid.org/0000-0001-7519-627X)
- Junping Shi (ORCID: https://orcid.org/0000-0001-9434-897X)
- Xiaoyuan Xu (ORCID: https://orcid.org/0000-0002-1759-4330)
- Zhong-Ping Duan
- Yuemin Nan (ORCID: https://orcid.org/0000-0003-4192-099X)
- Hui Zhuang (ORCID: https://orcid.org/0009-0002-0081-4322)
- Xiaoying Li (ORCID: https://orcid.org/0000-0001-6102-4856)
- Jie Li
- Jian‐Gao Fan (ORCID: https://orcid.org/0000-0002-8618-6402)
- C. N. Sun (ORCID: https://orcid.org/0000-0002-0006-1829)
- Rui-Xu Yang
- Vincent Wai-Sun Wong
Institutions
- Hebei Medical University (CN)
- Sun Yat-sen University (CN)
- Chinese University of Hong Kong (HK)
- Shanghai Jiao Tong University (CN)
- Capital Medical University (CN)
- Peking University (CN)
- Fudan University (CN)
- XinHua Hospital (CN)
- Third Hospital of Hebei Medical University (CN)
- Affiliated Hospital of Hangzhou Normal University (CN)
- Nanjing Drum Tower Hospital (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Peking University First Hospital (CN)
- Beijing YouAn Hospital (CN)
- Beijing Friendship Hospital (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Journal of Clinical and Translational Hepatology
- Published
- 2024-11-04
- DOI
- https://doi.org/10.14218/jcth.2024.00311
- Citations
- 52
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 20.10
Funders
- Capital Medical University
- Central South University
- Jilin University
- Chongqing Medical University
- Nankai University
- China Medical University
- Peking University
- Southwest Hospital
- Army Medical University
- Peking University People's Hospital
- National Science and Technology Major Project
- Xiangya Hospital, Central South University
- Shengjing Hospital
- First Hospital of Jilin University